amgen.com

amgen.com

Amgen
Monthly Visitors 115K
Global Rank 87560
Estimated Price $19,872

Summary

Domain age of Amgen.com is 26 years. Traffic is around 106K visitors during previous month, which corresponds to 87560 place in the global site ranking. During this month, traffic to site has increased by 7% compared to previous month, and equals to 115K visitors. Estimated potential revenue of this site may be up to $552 per month. We did not find any sites that have the same ID at Analytics and/or Adsence. According to our information, it is safe to visit Amgen.com.

Monthly Visitors

Now loading ...
Jun'17 (est) 115K
May'17 (est) 106K
Apr'17 (est) 109K
Mar'17 (est) 120K
Feb'17 (est) 88K
Jan'17 (est) 88K
Dec'16 (est) 81K
Nov'16 (est) 86K
Oct'16 (est) 117K
Sep'16 (est) 120K
Aug'16 (est) 129K
Jul'16 (est) 117K
Jun'16 (est) 136K
May'16 (est) 143K
Apr'16 (est) 140K
Mar'16 (est) 136K

SiteGur Score

Now loading ...
Jun'17 1183
May'17 -356
Apr'17 -523
Mar'17 1542
Feb'17 -408
Jan'17 1031
Dec'16 -338
Nov'16 -3818
Oct'16 605
Sep'16 -7
Aug'16 114
Jul'16 -1557
Jun'16 -485
May'16 931
Apr'16 698
Mar'16 223

Similar Sites

  • biooncology.com biooncology.com Cancer Education and Information | BioOncology Explore new research in cancer and learn how Genentech is dedicated to investigating diverse biological pathways and disease targets.
  • biocon.com biocon.com Biocon - Biocon is India's largest and fully-integrated, innovation-led biopharmaceutical company. It is committed to reduce therapy costs of chronic diseases like autoimmune, diabetes and cancer. Through innovative products and research services it is enabling access to affordable healthcare for patients, partners and healthcare systems across the globe. As an emerging global biopharmaceutical enterprise it has developed and taken a range of novel biologics, biosimilars, differentiated small molecules and Biocon is an innovation led fully integrated biopharmaceutical company that has developed affordable biosimilars, novel biologics and complex APIs. Leader in fermentation based biopharmaceuticals. Global scale manufacturing set up for biologics, biosimilars. High end scientific talent, research and development infrastructure. Largest Indian insulins company. Rich pipeline of biosimilars with nine products and novel biologics at various stages of clinical development including a high potential oral insulin. Novel Biologics, Biosimilars, Fermentation based APIs, statins, Tacrolimus, Sirolimus, Everolimus, Human Insulin, Glargine, Immunosuppresants, Monoclonal Antibody, Recombinant Proteins, Generic formulations, Trastuzumab, Itolizumab, Nimotuzamab, BioMab EGFR, Biopharmaceutical, Biotechnology Company, EGFR, GCSF, Fermentation, Orlistat, Insulin Lispro, Peptides, Insulin Aspart, diabetes, cancer, oncology, autoimmune, breast cancer, head neck cancer, psoriasis, chronic disease
  • dsi.com dsi.com Home - dsi.com Daiichi Sankyo Global Website
  • history.org history.org Home page of History.org : The Colonial Williamsburg Foundation's official History and Citizenship site
  • isfoundation.com isfoundation.com Welcome | Ian Somerhalder Foundation
  • ariad.com ariad.com ARIAD Home page Our mission is to discover, develop and commercialize small-molecule medicines to treat cancer in patients with the greatest unmet medical need—those with aggressive cancers where current therapies are inadequate. We are committed to the highest standards of integrity and stewardship in service to patients, the medical community, employees and shareholders.
  • wfhc.org wfhc.org Wheaton Franciscan Healthcare - Wheaton Franciscan Healthcare Wheaton Franciscan Healthcare is committed to living out the healing ministry of Jesus by providing exceptional and compassionate health care service.
  • genomichealth.com genomichealth.com Improving Cancer Outcomes with Genomic Intelligence | Genomic Health, Inc. Learn more about Genomic Health’s life changing work, transforming treatment decisions and outcomes in cancer delivering clinically actionable diagnostics and services.
  • bayer.us bayer.us Bayer United States of America Bayer U.S. is a subsidiary of Bayer AG, a global enterprise with core competencies in the fields of healthcare, agriculture and high-tech polymer materials.
  • ilsi.org ilsi.org ILSI - International Life Sciences Institute (ILSI)
  • show more...

Traffic Source

Now loading ...

Estimated Cost and Revenue

Amgen.com value: $19,872

Daily Ads revenue: $18

Monthly Ads revenue: $552

Yearily Ads revenue: $6,624

Now loading ...

Other information

Domain.com creation: 26 July 1990 expired: 25 July 2023
Archive.org information first time archived: 24 January 1999 last time archived: 09 July 2015 how many times: 1136

Whois report

Whois Server Version 2.0
Domain names in the .com and .net domains can now be registered
with many different competing registrars. Go to http://www.internic.net
for detailed information.
   Domain Name: AMGEN.COM
   Registrar: MARKMONITOR INC.
   Sponsoring Registrar IANA ID: 292
   Whois Server: whois.markmonitor.com
   Referral URL: http://www.markmonitor.com
   Name Server: NS1.AMGEN.COM
   Name Server: NS2.AMGEN.COM
   Name Server: NS3.AMGEN.COM
   Status: clientDeleteProhibited http://www.icann.org/epp#clientDeleteProhibited
   Status: clientTransferProhibited http://www.icann.org/epp#clientTransferProhibited
   Status: clientUpdateProhibited http://www.icann.org/epp#clientUpdateProhibited
   Status: serverDeleteProhibited http://www.icann.org/epp#serverDeleteProhibited
   Status: serverTransferProhibited http://www.icann.org/epp#serverTransferProhibited
   Status: serverUpdateProhibited http://www.icann.org/epp#serverUpdateProhibited
   Updated Date: 06-sep-2013
   Creation Date: 27-jul-1990
   Expiration Date: 26-jul-2023
>>> Last update of whois database: Mon, 07 Sep 2015 23:37:50 GMT <<<
NOTICE: The expiration date displayed in this record is the date the 
registrar's sponsorship of the domain name registration in the registry is 
currently set to expire. This date does not necessarily reflect the expiration 
date of the domain name registrant's agreement with the sponsoring 
registrar.  Users may consult the sponsoring registrar's Whois database to 
view the registrar's reported date of expiration for this registration.
TERMS OF USE: You are not authorized to access or query our Whois 
database through the use of electronic processes that are high-volume and 
automated except as reasonably necessary to register domain names or 
modify existing registrations; the Data in VeriSign Global Registry 
Services' ("VeriSign") Whois database is provided by VeriSign for 
information purposes only, and to assist persons in obtaining information 
about or related to a domain name registration record. VeriSign does not 
guarantee its accuracy. By submitting a Whois query, you agree to abide 
by the following terms of use: You agree that you may use this Data only 
for lawful purposes and that under no circumstances will you use this Data 
to: (1) allow, enable, or otherwise support the transmission of mass 
unsolicited, commercial advertising or solicitations via e-mail, telephone, 
or facsimile; or (2) enable high volume, automated, electronic processes 
that apply to VeriSign (or its computer systems). The compilation, 
repackaging, dissemination or other use of this Data is expressly 
prohibited without the prior written consent of VeriSign. You agree not to 
use electronic processes that are automated and high-volume to access or 
query the Whois database except as reasonably necessary to register 
domain names or modify existing registrations. VeriSign reserves the right 
to restrict your access to the Whois database in its sole discretion to ensure 
operational stability.  VeriSign may restrict or terminate your access to the 
Whois database for failure to abide by these terms of use. VeriSign 
reserves the right to modify these terms at any time. 
The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.
For more information on Whois status codes, please visit 
https://www.icann.org/resources/pages/epp-status-codes-2014-06-16-en.